(Q37317487)
Statements
Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors (English)
Reinhard Spanel
Georg Schöndorfer
Christian Dittrich
1 reference
scientific article published on 04 April 2016